Lactofiltrum tab. 500mg # 60

Dosage form

The tablets are dark brown in color with white-gray blotches, flat-cylindrical in shape, with a beveled and scored.

Structure

1 tab.

Hydrolysis lignin 355 mg

Lactulose 120 mg

Excipients: sodium croscarmellose, magnesium stearate.

pharmachologic effect

The pharmacological action of the drug LactofiltrumВ® is due to the properties of its active ingredients - lignin and lactulose.

Hydrolysis lignin is a natural enterosorbent, consisting of products of hydrolysis of wood components, has a high sorbing activity and nonspecific detoxification effect. Binds in the intestine and removes from the body pathogenic bacteria and bacterial toxins, drugs, heavy metal salts, alcohol, allergens, as well as excess of certain metabolic products, incl. bilirubin, cholesterol, histamine, serotonin, urea, and other metabolites responsible for the development of endogenous toxicosis.

Lactulose is a synthetic disaccharide, the molecule of which consists of galactose and fructose residues.

In the colon, lactulose as a substrate is fermented by normal intestinal microflora, stimulating the growth of bifidobacteria and lactobacilli.

As a result of hydrolysis of lactulose in the large intestine, organic acids are formed - lactic, acetic and formic, which suppress the growth of pathogenic microorganisms and, as a result, reduce the production of nitrogen-containing toxic substances.

The described process leads to an increase in osmotic pressure in the lumen of the large intestine and stimulation of peristalsis.

The complex action of the drug is aimed at normalizing the microbiocenosis of the large intestine and reducing the intensity of endogenous toxic conditions.

Pharmacokinetics

Hydrolytic lignin is not absorbed it is completely removed from the intestine within 24 hours.

Lactulose in the stomach and upper intestines is not absorbed or hydrolyzed.

Lactulose hydrolysis occurs in the colon.

Side effects

From the digestive system: rarely - flatulence, diarrhea.

Others: allergic reactions.

Selling features

Available without a prescription

Special conditions

The drug can be used in combination therapy with other drugs, subject to the rules of separate administration.

Indications

- violations of the intestinal microflora, incl.

as a result of antibiotic therapy

- irritable bowel syndrome (as part of complex therapy)

- hepatitis and cirrhosis of the liver (as part of complex therapy)

- allergic diseases (atopic dermatitis, urticaria) - as part of complex therapy.

Contraindications

- intestinal obstruction

- gastrointestinal bleeding

- galactosemia

- hypersensitivity to the drug.

The drug should be used with caution in case of exacerbation of gastric ulcer and duodenal ulcer, intestinal atony.

Drug interactions

It is possible to reduce the therapeutic effect of some simultaneously taken orally drugs.

Dosage

The tablets are taken orally, if necessary, after preliminary grinding, with water, 1 hour before meals and taking other medicines.

Adults and children over 12 years old are prescribed 2-3 tablets 3, children aged 8 to 12 years - 1-2 tablets 3, children aged 3 to 7 years - 1 tablet 3, children aged 1 year up to 3 years - 1/2 tablet 3

The average duration of the course of treatment is 2-3 weeks.

Long-term use of the drug and repeated courses of treatment should be carried out only on the recommendation of a doctor.

Overdose

Symptoms: constipation, abdominal pain.

Treatment: discontinuation of the drug.

Name ENG

LACTOFILTRUM

Clinical and pharmacological group

Enterosorbent regulating the balance of intestinal microflora

ATX code

Other intestinal adsorbents

Dosage

120mg + 355mg

Structure

Hydrolytic lignin 355 mg.

Lactulose 120 mg.

Excipients: sodium croscarmellose, magnesium stearate.

Indications

Intestinal microflora disorders, incl.

as a result of antibiotic therapy

irritable bowel syndrome (as part of complex therapy)

hepatitis and cirrhosis of the liver (as part of complex therapy)

allergic diseases (atopic dermatitis, urticaria) - as part of complex therapy.

INN / Active ingredient

lactulose, hydrolytic lignin

Storage conditions and periods

In a dry, dark place, at a temperature not exceeding 30 degrees.

Expiration date: 3 years

Contraindications

Bowel obstruction

gastrointestinal bleeding

galactosemia

hypersensitivity to the drug.

Specifications

Scope of the medicinal product

Gastrointestinal tract

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

60

Scope of application

Gastroenterology

Minimum age from

1 year

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

OTCPharm

The amount of the dosage form in the primary package

15 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Enterosorbent agent

Anatomical and therapeutic characteristics

A07BC Other absorbent intestinal preparations

Dosage form

Pills

The target audience

Adult

Dosage (volume) of the substance in the preparation

1 tab.

- Hydrolytic lignin 355 mg, Lactulose 120 mg

Expiration date in days

1095

Package weight, g

70

Category

:

Enterosorbents and antidotes

,

Dysbacteriosis

,

Probiotics and prebiotics

,

Inulins

Mode of application

:

The tablets are taken orally, if necessary, after preliminary grinding, with water, 1 hour before meals and taking other medicines.

Information on technical characteristics, delivery set, country of manufacture